Literature DB >> 26091718

Age-Associated Failure To Adjust Type I IFN Receptor Signaling Thresholds after T Cell Activation.

Guangjin Li1, Jihang Ju1, Cornelia M Weyand1, Jörg J Goronzy2.   

Abstract

With increasing age, naive CD4 T cells acquire intrinsic defects that compromise their ability to respond and differentiate. Type I IFNs, pervasive constituents of the environment in which adaptive immune responses occur, are known to regulate T cell differentiation and survival. Activated naive CD4 T cells from older individuals have reduced responses to type I IFN, a defect that develops during activation and that is not observed in quiescent naive CD4 T cells. Naive CD4 T cells from young adults upregulate the expression of STAT1 and STAT5 after activation, lowering their threshold to respond to type I IFN stimulation. The heightened STAT signaling is critical to maintain the expression of CD69 that regulates lymphocyte egress and the ability to produce IL-2 and to survive. Although activation of T cells from older adults also induces transcription of STAT1 and STAT5, failure to exclude SHP-1 from the signaling complex blunts their type I IFN response. In summary, our data show that type I IFN signaling thresholds in naive CD4 T cells after activation are dynamically regulated to respond to environmental cues for clonal expansion and memory cell differentiation. Naive CD4 T cells from older adults have a defect in this threshold calibration. Restoring their ability to respond to type I IFN emerges as a promising target to restore T cell responses and to improve the induction of T cell memory.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26091718      PMCID: PMC4506866          DOI: 10.4049/jimmunol.1402389

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

Review 1.  Interferon signalling network in innate defence.

Authors:  Akinori Takaoka; Hideyuki Yanai
Journal:  Cell Microbiol       Date:  2006-06       Impact factor: 3.715

2.  Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.

Authors:  Robert B Couch; Patricia Winokur; Rebecca Brady; Robert Belshe; Wilbur H Chen; Thomas R Cate; Bryndis Sigurdardottir; Amy Hoeper; Irene L Graham; Robert Edelman; Fenhua He; Diane Nino; Jose Capellan; Frederick L Ruben
Journal:  Vaccine       Date:  2007-09-14       Impact factor: 3.641

3.  Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels.

Authors:  Grazia Galli; Duccio Medini; Erica Borgogni; Luisanna Zedda; Monia Bardelli; Carmine Malzone; Sandra Nuti; Simona Tavarini; Chiara Sammicheli; Anne K Hilbert; Volker Brauer; Angelika Banzhoff; Rino Rappuoli; Giuseppe Del Giudice; Flora Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 4.  Type I interferons as vaccine adjuvants against infectious diseases and cancer.

Authors:  Laura Bracci; Valentina La Sorsa; Filippo Belardelli; Enrico Proietti
Journal:  Expert Rev Vaccines       Date:  2008-04       Impact factor: 5.217

Review 5.  Systems biology of vaccination in the elderly.

Authors:  Sai S Duraisingham; Nadine Rouphael; Mary M Cavanagh; Helder I Nakaya; Jorg J Goronzy; Bali Pulendran
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

6.  Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice.

Authors:  Jincun Zhao; Jingxian Zhao; Kevin Legge; Stanley Perlman
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

7.  Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway.

Authors:  M You; D H Yu; G S Feng
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

8.  PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity.

Authors:  Bin Liu; Sheldon Mink; Kelly A Wong; Natalie Stein; Crescent Getman; Paul W Dempsey; Hong Wu; Ke Shuai
Journal:  Nat Immunol       Date:  2004-08-15       Impact factor: 25.606

Review 9.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

10.  Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1.

Authors:  M David; H E Chen; S Goelz; A C Larner; B G Neel
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

View more
  26 in total

Review 1.  Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis.

Authors:  Elena Grebenciucova; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

Review 2.  The life cycle of a T cell after vaccination - where does immune ageing strike?

Authors:  C Kim; F Fang; C M Weyand; J J Goronzy
Journal:  Clin Exp Immunol       Date:  2016-08-15       Impact factor: 4.330

3.  Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans.

Authors:  Shai S Shen-Orr; David Furman; Brian A Kidd; Francois Hadad; Patricia Lovelace; Ying-Wen Huang; Yael Rosenberg-Hasson; Sally Mackey; Fatemeh A Gomari Grisar; Yishai Pickman; Holden T Maecker; Yueh-Hsiu Chien; Cornelia L Dekker; Joseph C Wu; Atul J Butte; Mark M Davis
Journal:  Cell Syst       Date:  2016-10-13       Impact factor: 10.304

Review 4.  Successful and Maladaptive T Cell Aging.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Immunity       Date:  2017-03-21       Impact factor: 31.745

5.  Low IL-2 Expressing T Cells in Thalassemia Major Patients: Is It Immune Aging.

Authors:  Batoul Pourgheysari; Leila Karimi; Raihaneh Bagheri; Soleiman Kheiri
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-07       Impact factor: 0.900

Review 6.  The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Aleš Goropevšek; Marija Holcar; Tadej Avčin
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

Review 7.  Hallmarks of the aging T-cell system.

Authors:  Huimin Zhang; Cornelia M Weyand; Jörg J Goronzy
Journal:  FEBS J       Date:  2021-03-03       Impact factor: 5.622

Review 8.  Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change.

Authors:  Tamas Fulop; Anis Larbi; Graham Pawelec; Alan A Cohen; Guillaume Provost; Abedelouahed Khalil; Guy Lacombe; Serafim Rodrigues; Mathieu Desroches; Katsuiku Hirokawa; Claudio Franceschi; Jacek M Witkowski
Journal:  Vaccines (Basel)       Date:  2022-04-13

Review 9.  Immunology of SARS-CoV-2 infection in children.

Authors:  Janet Chou; Paul G Thomas; Adrienne G Randolph
Journal:  Nat Immunol       Date:  2022-02-01       Impact factor: 31.250

10.  Modeling the dynamics of neonatal CD8+ T-cell responses.

Authors:  Arnold Reynaldi; Norah L Smith; Timothy E Schlub; Vanessa Venturi; Brian D Rudd; Miles P Davenport
Journal:  Immunol Cell Biol       Date:  2016-05-04       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.